XILA-10® - Injectable solution


Sedative - Analgesic

Xila-10®, an injectable solution, produces a state of sedation accompanied by general muscle relaxation and a reduction in painful sensations. Due to its pharmacological properties it is indicated in:
- Handling and transporting excessively nervous or aggressive animals.
- Diagnostic procedures.
- Dental procedures.
- Minor surgeries of short duration, such as: cleaning and suturing of wounds, removal of dermal neoplasms, etc.
- Orthopedic procedures such as plucking and shoeing.
- Pre-anesthesia in major or prolonged surgeries, with general or local anesthetics.

Technical Specification

Species


Horses and cattle.

Dosage form


Injectable solution.

Therapeutic action


Sedative - Analgesic

Composition


Each 1 mL of solution contains:
Xylazine Hydrochloride ............... 117 mg
(equivalent to 100 mg of Xylazine base)
Excipients q.s.p ............................ 1 mL

Indications


Xila-10®, an injectable solution, produces a state of sedation accompanied by general muscle relaxation and a reduction in painful sensations. Due to its pharmacological properties it is indicated in:
- Handling and transporting excessively nervous or aggressive animals.
- Diagnostic procedures.
- Dental procedures.
- Minor surgeries of short duration, such as: cleaning and suturing of wounds, removal of dermal neoplasms, etc.
- Orthopedic procedures such as plucking and shoeing.
- Pre-anesthesia in major or prolonged surgeries, with general or local anesthetics.

Mode of application


Intravenous administration should be done slowly.
After the injection of Xila-10®, the animal should be kept at rest until the desired effect has been achieved.

Route od administration and dosage


Administration by slow intravenous or intramuscular route, in a single dose.


Dosage of the active ingredient:


Horses: 0.6 - 1.1 mg/Kg, by slow IV route.
2.2 - 3.0 mg/Kg, IM.
Cattle: 0.05 - 0.3 mg/Kg, by IM route.


Product dosage:


Horses: 0.6 - 1.1 mL / 100 Kg, by slow IV route
2.2 - 3.0 mL / 100 Kg, IM.
Cattle: 0.05 - 0.3 mL / 100 Kg, by IM route.

After the injection of Xila-10, the animal should be kept at rest until the desired effect has been achieved.

Drug interactions


Xylazine should not be used in joint therapy with neuroleptics or tranquilizers. The use of Xylazine and barbiturates causes additive depressant effects; the use of barbiturates to induce anesthesia should be at a reduced dose level and administered slowly when injected intravenously.
Xylazine should not be used concomitantly with adrenoreceptor stimulants (Adrenaline, Noradrenaline, Dopamine).

Contraindications


  • Do not use concomitantly with adrenoreceptor stimulants (Adrenaline, Noradrenaline, Dopamine).
  • Do not administer to animals with ventricular arrhythmias.
  • Do not use in animals with intestinal obstruction or intestinal impaction.
  • Do not administer in pregnant females in the last third of gestation, except during delivery.
  • Do not administer in lactating females.

Special precautions for use


Special warnings and precautions for use:

  • To achieve the desired effect, during the administration of the drug the animal must be calm and fasting for at least 6 hours.
  • Use with caution in animals with lung conditions, liver or kidney dysfunction, severe heart disease, shock, or that are under stress conditions, such as extreme heat or cold, at altitude, fatigued.
  • Keep out of the reach of children.

Special precautions for the operator


  • Wash your hands after administering the product.
  • While handling the product, do not eat, drink liquids, or smoke.
  • Avoid contact with skin and eyes.
  • In the case of contact with the eyes, it is recommended to wash with plenty of water for 15 minutes.
  • In case of accidental ingestion, call a doctor or a poison information center. Do not induce vomiting.
  • In case of accidental self-injection, consult a doctor immediately.

Warnings


Keep out of the reach of children.

Adverse effects


  • In horses, at therapeutic doses it can occasionally cause mild muscle tremor, bradycardia with partial AV block, and a decrease in respiratory rate.
  • In cattle, profuse salivation and ruminal atony may occur.

Guard period


Meat: 2 days. Do not administer to horses whose meat is intended for human consumption.

Milk: 2 days.

Observations


Special precautions for disposal of unused product or waste material:
Dispose of the waste of this product with care together with household waste. Do not dispose of containers with product remains on the ground or water courses. For expired or unused products, contact the manufacturing laboratory.

Conservation


Store between 15 and 30°C, protected from light. Once the container is opened, use within 28 days. Discard unused product after that period of time.

Condition of sale


Chile: Sale under Veterinary Medical prescription withheld.
Peru: Under restricted prescription prescription.
Other countries: Sale under Veterinary Medical prescription.

Presentation


50 mL vial

Prepared by


Laboratory Drag Pharma Chile Invetec S.A.

Records


Chile: Reg. SAG N° 1837

Rep. Dominicana: Reg. No 9102

Perú: Reg. SENASA F.79.01.I.0004

Bolivia: Reg. SENASAG PUV-No 009991/21

Available for sale


Imported and distributed in Bolivia by:
ZOOFARMA
TEL: +(591)222-3357
Street Díaz Romero 1339, La Paz.

You have entered drug info or veterinary products intended exclusively (s) kind (s) indicated (s).

Drag Pharma Lab is not responsible for the consequences of misuse of the products, and the use of this information without consulting a veterinarian